# Teleflex Inc (TFX)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/teleflex-inc/ JSON: https://steadybase.io/company/teleflex-inc.json Checked Nov 10, 2026. Latest filing read: Nov 5, 2026.

## Company

- Legal name: TELEFLEX INC
- Ticker: TFX (NYSE)
- SEC CIK: 0000096943
- Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
- Headquarters: Wayne, PA
- Fiscal year ends: December 31
- SEC filer category: Large accelerated filer
- Website: teleflex.com
- LinkedIn: https://www.linkedin.com/company/teleflex
- Next earnings date: Dec 24, 2026 (estimated from past 8-K timing)

## Key facts

- Revenue: $2.0B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 27, 2026). Source: https://www.sec.gov/Archives/edgar/data/96943/000009694326000019/0000096943-26-000019-index.html
- Operating income: $118.4M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 27, 2026). Source: https://www.sec.gov/Archives/edgar/data/96943/000009694326000019/0000096943-26-000019-index.html
- Net income: -$905.6M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 27, 2026). Source: https://www.sec.gov/Archives/edgar/data/96943/000009694326000019/0000096943-26-000019-index.html
- SG&A: $720.2M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 27, 2026). Source: https://www.sec.gov/Archives/edgar/data/96943/000009694326000019/0000096943-26-000019-index.html
- Employees: 15,500 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/96943/000009694326000019/tfx-20251231.htm
- Shares outstanding: 39,661,261 as of Nov 3, 2026 (10-Q filed Nov 5, 2026). Source: https://www.sec.gov/Archives/edgar/data/96943/000009694326000109/0000096943-26-000109-index.html
- Auditor: Pricewaterhousecoopers LLP, Philadelphia, Pennsylvania, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/96943/000009694326000019/tfx-20251231.htm

## Business

Teleflex is a global provider of medical technology products that enhance clinical benefits, improve patient and provider safety and reduce total procedural costs. We primarily design, develop, manufacture and supply single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. We market and sell our products to hospitals and healthcare providers worldwide through a combination of our direct sales force and distributors.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/96943/000009694326000019/tfx-20251231.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $2.0B | $118.4M | -$905.6M | $720.2M |
| Dec 31, 2024 | $1.7B | $103.7M | $69.7M | $674.5M |
| Dec 31, 2023 | $1.7B | $258.7M | $356.3M | $622.7M |
| Dec 31, 2022 | $2.8B | $499.7M | $363.1M | $863.7M |
| Dec 31, 2021 | $2.8B | $628.1M | $485.4M | $860.1M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/teleflex-inc.json

## Officers and directors

- Jason R. Weidman, President and CEO. Source: Form 4 filed Jun 9, 2026, https://www.sec.gov/Archives/edgar/data/96943/000009694326000076/0000096943-26-000076-index.htm
- Stuart A. Randle, Interim President and Chief Executive Officer. Source: 8-K filed Jun 9, 2026, https://www.sec.gov/Archives/edgar/data/96943/000009694326000072/tfx-20260608.htm
- John Deren, Executive Vice President & CFO. LinkedIn: https://linkedin.com/in/john-deren-4aabb115. Source: Form 4 filed Mar 5, 2026, https://www.sec.gov/Archives/edgar/data/96943/000170618926000004/0001706189-26-000004-index.htm
- John R. Deren, Executive Vice President and Chief Financial Officer. Source: 10-K filed Feb 27, 2026, https://www.sec.gov/Archives/edgar/data/96943/000009694326000019/tfx-20251231.htm
- Daniel V. Logue, Corporate Vice President, General Counsel & Secretary. Source: 8-K filed Sep 9, 2026, https://www.sec.gov/Archives/edgar/data/96943/000009694326000101/tfx-20260908.htm
- Cameron P. Hicks, Corp. VP & Chief HR Officer. Source: Form 4 filed Mar 5, 2026, https://www.sec.gov/Archives/edgar/data/96943/000162703626000004/0001627036-26-000004-index.htm
- Stephen K. Klasko, M.D., independent Chair of the Board. Source: 10-K filed Feb 27, 2026, https://www.sec.gov/Archives/edgar/data/96943/000009694326000019/tfx-20251231.htm
- Dominik Michal Reterski, Corporate Vice President, QARA. Source: Form 3 filed Apr 13, 2026, https://www.sec.gov/Archives/edgar/data/96943/000212949926000003/0002129499-26-000003-index.htm
- Sean M. Salmon, director. Source: 8-K filed Sep 9, 2026, https://www.sec.gov/Archives/edgar/data/96943/000009694326000101/tfx-20260908.htm
- James Winters, Corp VP, Mfg and Supply. Source: Form 4 filed Mar 5, 2026, https://www.sec.gov/Archives/edgar/data/96943/000180414926000004/0001804149-26-000004-index.htm
- Andrew A. Krakauer, Board member (per proxy). Source: DEF 14A filed Apr 13, 2026, https://www.sec.gov/Archives/edgar/data/96943/000009694326000039/tfx-20260413.htm
- Candace H. Duncan, Board member (per proxy). Source: DEF 14A filed Apr 13, 2026, https://www.sec.gov/Archives/edgar/data/96943/000009694326000039/tfx-20260413.htm
- Gretchen R. Haggerty, Board member (per proxy). Source: DEF 14A filed Apr 13, 2026, https://www.sec.gov/Archives/edgar/data/96943/000009694326000039/tfx-20260413.htm
- Jaewon Ryu, M.D., Board member (per proxy). Source: DEF 14A filed Apr 13, 2026, https://www.sec.gov/Archives/edgar/data/96943/000009694326000039/tfx-20260413.htm
- James P. Winters, Named in proxy. LinkedIn: https://linkedin.com/in/james-winters-52908714. Source: DEF 14A filed Apr 13, 2026, https://www.sec.gov/Archives/edgar/data/96943/000009694326000039/tfx-20260413.htm
- Michael J. Tokich, Board member (per proxy). Source: DEF 14A filed Apr 13, 2026, https://www.sec.gov/Archives/edgar/data/96943/000009694326000039/tfx-20260413.htm
- Neena M. Patil, Board member (per proxy). Source: DEF 14A filed Apr 13, 2026, https://www.sec.gov/Archives/edgar/data/96943/000009694326000039/tfx-20260413.htm

## Recent 8-K events

- Nov 5, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/96943/000009694326000107/tfx-20261105.htm
- Sep 9, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/96943/000009694326000101/tfx-20260908.htm
- Aug 7, 2026: Item 8.01, Other events. Source: https://www.sec.gov/Archives/edgar/data/96943/000009694326000097/tfx-20260807.htm
- Aug 6, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/96943/000009694326000091/tfx-20260806.htm
- Aug 3, 2026: Item 2.01, Completion of acquisition or disposition of assets; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/96943/000009694326000084/tfx-20260803.htm
- Jun 15, 2026: Item 1.01, Entry into a material definitive agreement; Item 2.03, Creation of a direct financial obligation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/96943/000119312526271318/d138783d8k.htm
- Jun 9, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/96943/000009694326000072/tfx-20260608.htm
- Jun 2, 2026: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/96943/000119312526251951/d71849d8k.htm
- Jun 1, 2026: Item 7.01, Regulation FD disclosure; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/96943/000119312526249764/d126202d8k.htm
- May 27, 2026: Item 1.01, Entry into a material definitive agreement; Item 2.03, Creation of a direct financial obligation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/96943/000119312526242184/d126197d8k.htm

## Insider trades (Form 4)

- Aug 6, 2025: Gretchen R. Haggerty (Director) bought 500 shares, about $57,375. Source: https://www.sec.gov/Archives/edgar/data/96943/000009694325000124/0000096943-25-000124-index.htm
- Aug 5, 2025: Stuart A. Randle (Director) bought 1,000 shares, about $115,860. Source: https://www.sec.gov/Archives/edgar/data/96943/000009694325000130/0000096943-25-000130-index.htm
- Aug 5, 2025: Andrew A. Krakauer (Director) bought 1,000 shares, about $115,250. Source: https://www.sec.gov/Archives/edgar/data/96943/000009694325000127/0000096943-25-000127-index.htm
- Aug 5, 2025: Liam Kelly (Chairman, President & CEO) bought 1,500 shares, about $172,605. Source: https://www.sec.gov/Archives/edgar/data/96943/000009694325000126/0000096943-25-000126-index.htm
- Aug 5, 2025: Jaewon Ryu (Director) bought 1,500 shares, about $172,500. Source: https://www.sec.gov/Archives/edgar/data/96943/000009694325000125/0000096943-25-000125-index.htm

## What management said

- "We are pleased with our third quarter performance, which included margin expansion and robust earnings per share growth, even when excluding IEEPA tariff refunds" Jason Weidman, Teleflex’s President and Chief Executive Officer (8-K filed Nov 5, 2026). Source: https://www.sec.gov/Archives/edgar/data/96943/000009694326000107/ex991to11-5x2026req32026ea.htm

## Latest filings

- 8-K filed Sep 9, 2026: https://www.sec.gov/Archives/edgar/data/96943/000009694326000101/tfx-20260908.htm
- 10-K filed Feb 27, 2026: https://www.sec.gov/Archives/edgar/data/96943/000009694326000019/tfx-20251231.htm
- 10-Q filed Aug 6, 2026: https://www.sec.gov/Archives/edgar/data/96943/000009694326000095/tfx-20260630.htm
- DEF 14A filed Apr 13, 2026: https://www.sec.gov/Archives/edgar/data/96943/000009694326000039/tfx-20260413.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/